top of page

Charalampos Fotsitzoudis

Oncologist

dct-VhrachimisAl.jpg

Working Experience 


March 2025 - Present

Medican Oncologist, Consultant German Medical Institute, Limassol, Cyprus


February 2023 - December 2024

Sub-Investigator, Clinical Trials department, Department of Medical Oncology, University Hospital of Heraklion More than 30 clinical trials, mainly intervantional: breast, lung, pancreas, colorectal, basket trials etc- phase I/II/III


Αugust 2020 - February 2023

Resident of Medical Oncology, Department of Oncology, University Hospital of Heraklion, Crete, Greece


August 2018 - August 2020

Resident of Medical Oncology- General Cancer Hospital of Pireus ‘Metaxa’, Pireus, Greece - August 2018- September 2019: Department of Internal Medicine - October 2019- March 2020: Department of Oncology - April 2020-August 2020: Department of Transplantation



Education


September 2022 - October 2023

Greek Academy of Oncology, 8th cycle


April 2024 - ongoing

PhD candidate, Laboratory of Translational Oncology, Medical School, University of Crete, Heraklion, Greece. Thesis: ‘Investigation of the expression of Trop-2 and PD-L1 in the primary tumor and in the periphery in patients with triplenegative breast cancer: correlation with clinicopathological data and outcome’.


October 2011 -April 2018

Medical School, Meical University of Plovdiv, Bulgaria


2008-2011

High school: Lyceium of Didymoteicho, Evros. Greece Grade 19.1/20



Language and Other qualifications


Greek (mother tongue)

English (fluently), Certificate of Proficiency in English, University of Michigan

German (good), Geothe – Zertifikat B1

Bulgarian (good)


Computer/programming knowledge: excellent knowledge of windows and office (word, excel, powerpoint)



Accreditations


September 2021

Distance learning course: ‘Oncogenomics for health professionals’ , Instituto Superiore di Sanita and Universita Cattolica del Sacro Cuore, Rome, Italy


December 2022

Good Clinical Pracice (GCP) certification



Publications


September 2022

Cancer-Associated Fibroblasts: The Origin, Biological Characteristics and Role in Cancer-A Glance on Colorectal Cancer’. Fotsitzoudis C, Koulouridi A, Messaritakis I, Konstantinidis T, Gouvas N, Tsiaoussis J, Souglakos J. Cancers


August 2024

Prognostic Value of Fas/Fas Ligand Expression on Circulating Tumor Cells (CTCs) and Immune Cells in the Peripheral Blood of Patients with Metastatic Breast Cancer Maria A. Papadaki, Eleni Papadaki, Sofia Chatziavraam, Despoina Aggouraki, Kleita Michaelidou, Charalampos Fotsitzoudis, Maria Vassilakopoulou, Dimitrios Mavroudis and Sofia Agelaki Cancers


August 2024

Blood immunomap for prediction of responses to aPD1 immunotherapy in metastatic non-small cell lung cancer. Maria Semitekolou, Nikolaos Paschalidis,Domenico Lo Tartaro, Aikaterini Tsitsopoulou, Panagiota Stamou, Alexandros Mavroudis, Effrosyni Markaki, Athina Varveri, Ioannis Morianos, Matthieu Lavigne, Charalampos Fotsitzoudis, Sophia Magkouta, Konstantina Dede, Ioannis Kalomenidis, Konstantinos Samitas, Konstantinos Potaris, Andrea Cossarizza, Dimitrios Mavroudis, Sara De Biasi, Panayiotis Verginis


June 2025

Comparative analysis of TROP2 expression in tumor tissues and circulating tumor cells (CTCs) in the peripheral blood of patients with triple negative breast cancer Dimitrios Mavroudis; Eleni Lagoudaki; Sofia Gounaki; Sofia Hatziavraam; Charalampos Fotsitzoudis; Kleita Michaelidou; Sofia Agelaki; Maria A Papadaki


January 2026

Ulcerated Achilles Lesion Revealing Extensive Gouty Tophi in a Patient Under Chemotherapy

International Journal of Rheumatic Diseases



Seminars – Congresses


Participation in national / international conferences / seminars, including active participation (presentation)



Member of Scientific Committee


August 2020

Member of Heraklion Medical Association


September 2022

Member of young Greek Oncologists group (ONEO)


February 2023

Member of European Society of Oncology(ESMO)

bottom of page